Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Mother Gives Birth To Twins With Different Fathers, US
11-month old Dallas-born twins Justin and Jordan have different fathers, a phenomenon known as heteropaternal superfecundation that is so rare there
generic viagra online
Final Analysis Shows HPV Vaccine Highly Effective At Preventing Precancerous Cervical Lesions
The final analysis of the PATRICIA study shows that the HPV-16/18 AS04-adjuvanted vaccine (GlaxoSmithKline) has high efficacy against the precancerous cervical lesions that can eventually lead to cervical cancer. The vaccine also shows cross-protective efficacy against other oncogenic (cancer-causing) HPV types closely related to HPV-16/18. Furthermore, it also shows efficacy in the cohorts relevant to universal mass vaccination and catch-up programmes. The findings are reported in an Article Online First and in an upcoming edition of The Lancet, written by Dr Jorma Paavonen, University of Helsinki, Finland, and colleagues.
News of the day
Oregon Hospital Building Boom Slows Down
"Oregon"s hospital spending boom is winding to a close," as hospitals cut back on projects, Portland Business Journal reports. "Portland-area hospitals have opened, started construction on, or announced expansions costing at least $1.3 billion in the past 18 months. Projects include cancer treatment centers, cardiac units and pediatric care facilities. Now, spurred by economic concerns, health organizations are cutting back. ... It doesn"t make financial sense to embark on major new projects until the economy improves and hospital administrators know how health care reforms may affect their operations, said Providence Chief Operating Officer Terry Smith."
Endocrinology

King Saud University Scientist Part Of Cancer Breakthrough

King Saud University professor, Dr. Adel Almogren, along with a diverse team of academic researchers from the United States, Canada, and Taiwan, has discovered a new process that could lead to a vaccine to block cancer cell adhesion and growth. In the upcoming issue of NeoPlasia, an international oncology research journal, Dr. Almogren and his colleagues describe their efforts to use monoclonal antibodies to block the tumor process and increase cancer survival rates. Monoclonal antibodies are produced by one type of immune cell that are clones, or mimics, of a parent cell. Successful Petri dish experiments indicate that vaccinations with these peptide mimics may be able to block a common tumor-causing carbohydrate known as Thomsen-Friedenreich. Dr. Almogren is an Assistant Professor in the College of Medicine"s Pathology Department at King Saud University. He earned his PhD in immunology from the University of Dundee in Scotland and has been on the KSU faculty since 2003. His participation in this scientific breakthrough is indicative of the recent trend of rapid growth in innovation at KSU and throughout the Kingdom of Saudi Arabia. The university has been aggressively recruiting world-class researchers and ramping up its patenting and technology transfer activities. To support academic researchers and entrepreneurial students, King Saud University has invested heavily in a wide array of initiatives to include the development of Riyadh Techno Valley, a public-private research park on the edge of campus, and the Riyadh Technology Incubation Center, a program to help university-based startup companies. To review the complete article, please click here. King Saud University


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009